Skip to main content
MedApt
  • Log in
Sub Sub Speciality
Miscellaneous
Code
TMMSC1

Adjunctive Dapagliflozin Demonstrated Higher TIR Than Acarbose in T1DM

Submitted by centrix_admin on Sat, 06/06/2026 - 15:08
Tags
α-Glucosidase inhibitors
SGLT-2 Inhibitor
Continuous glucose monitoring (CGM)
  • Read more about Adjunctive Dapagliflozin Demonstrated Higher TIR Than Acarbose in T1DM

Triple FDC Improved HbA1c More Than Dual Therapies in T2DM

Submitted by centrix_admin on Thu, 04/16/2026 - 19:59
Tags
hBA1c
Sulphonylureas
Biguanide
α-Glucosidase inhibitors
  • Read more about Triple FDC Improved HbA1c More Than Dual Therapies in T2DM

Global Survey Reports Perceived Disparities in Diabetes Drug Access

Submitted by centrix_admin on Mon, 02/16/2026 - 22:40
Tags
Rapid acting
short acting
Long acting
α-Glucosidase inhibitors
SGLT-2 Inhibitor
  • Read more about Global Survey Reports Perceived Disparities in Diabetes Drug Access

Gender and Wealth Gaps Widen Type 2 Diabetes Crisis in China

Submitted by centrix_admin on Sat, 01/17/2026 - 08:06
Tags
α-Glucosidase inhibitors
SGLT-2 Inhibitor
  • Read more about Gender and Wealth Gaps Widen Type 2 Diabetes Crisis in China
Subscribe to α-Glucosidase inhibitors